CTKB - Cytek Biosciences, Inc.

QQQ $ 622.38 $ 4.94 (0.8 %)

DIA $ 473.04 $ 2.23 (0.47 %)

SPY $ 677.28 $ 2.47 (0.37 %)

TLT $ 89.01 $ -0.57 (-0.64 %)

GLD $ 365.20 $ 0.10 (0.03 %)

Previous Close

$ 4.01

Open

$ 3.93

Bid

$ 3.75 x 3

Ask

$ 4.75 x 50

Day's Range

$ 3.86 - $ 4.02

52 Week Range

$ 2.37 - $ 7.63

Volume

954,476

Average Volume

Market Cap

510.17M

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-27-2025	12-31-2024	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	03-13-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-01-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-10-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	03-17-2022	12-31-2021	10-K
17	11-12-2021	09-30-2021	10-Q
18	09-02-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cytek Biosciences Affirms FY2025 Sales Gui...
11/05/2025 21:32:09

Cytek Biosciences (NASDAQ:CTKB) affirms FY2025 sales outlook from $196.000 million-$205.000 million to $196.000 million-$205.00...

Cytek Biosciences Q3 EPS $(0.04) Beats $(0...
11/05/2025 21:31:19

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

Cytek Biosciences Announces The Relocation...
10/15/2025 21:04:49

FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for ...

Cytek Biosciences Narrows FY2025 Sales Gui...
08/06/2025 20:28:43

Cytek Biosciences (NASDAQ:CTKB) narrows FY2025 sales outlook from $196.000 million-$210.000 million to $196.000 million-$205.00...

Cytek Biosciences Q2 EPS $(0.04), Inline, ...
08/06/2025 20:11:18

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This i...

Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

Cytek Biosciences Launches Cytek Aurora Ev...
05/29/2025 21:05:23

Beyond The Numbers: 4 Analysts Discuss Cyt...
05/28/2025 19:00:32

Morgan Stanley Maintains Equal-Weight on C...
05/28/2025 16:11:15

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight and lowers the price targe...

dht-holdings-posts-weak-sales-joins-compass-diversified-okta-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

DHT Holdings Posts Weak Sales, Joins Compa...
05/28/2025 12:24:06

Goldman Sachs Maintains Sell on Cytek Bios...
05/12/2025 17:03:46

Goldman Sachs analyst Matthew Sykes maintains Cytek Biosciences (NASDAQ:CTKB) with a Sell and lowers the price target from $...

Cytek Biosciences Lowers FY2025 Sales Guid...
05/08/2025 20:43:44

Cytek Biosciences (NASDAQ:CTKB) lowers FY2025 sales outlook from $204.00 million-$212.00 million to $196.00 million-$210.00 mil...

Cytek Biosciences Q1 EPS $(0.09) Misses $(...
05/08/2025 20:26:00

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $...

Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

Cytek Biosciences Showcases Its Patented F...
04/29/2025 21:05:15

Stephens & Co. Reiterates Overweight on Cy...
03/19/2025 14:07:32

Stephens & Co. analyst Mason Carrico reiterates Cytek Biosciences (NASDAQ:CTKB) with a Overweight and maintains $6 price...

Piper Sandler Maintains Overweight on Cyte...
03/04/2025 15:45:54

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

Cytek Biosciences Sees FY2025 Sales $204.0...
02/27/2025 21:24:25

Cytek Biosciences (NASDAQ:CTKB) sees FY2025 sales of $204.000 million-$212.000 million vs $219.60 million analyst estimate.

Cytek Biosciences Q4 EPS $0.07 Beats $0.05...
02/27/2025 21:23:38

Cytek Biosciences (NASDAQ:CTKB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0....